National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 57879 [2019-23553]
Download as PDF
<![CDATA[
57879
Federal Register / Vol. 84, No. 209 / Tuesday, October 29, 2019 / Notices
Need and Proposed Use of the
Information: Funds appropriated for the
NAT Program are distributed among
eligible institutions based on a formula,
as permitted by PHS Act section
806(e)(1). HRSA uses the data from the
NAT Tables to determine if the Funding
Factors (either the Statutory Funding
Preference or Special Consideration) are
met, determine the award amount,
ensure compliance with programmatic
and grant requirements, and provide
information to the public and Congress.
The NAT Tables currently collect one
year of data, which allows HRSA to
calculate award amounts for a singleyear project period. For fiscal year 2020,
HRSA is revising the forms that
previously collected one year of data on
prospective students to capture three
years of data, thereby allowing HRSA to
calculate award amounts for a multiyear project period. Table 1 will add
columns to collect Year 2 and Year 3
data for the number of prospective
students. While Table 2 data collection
elements will not change, the header
will change to provide further
clarification about the data being
collected.
Likely Respondents: Respondents will
be applicants to HRSA’s NAT Program.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Table 1—NAT: Enrollment, Traineeship Support, Graduate, Graduates Supported and Projected Data .............
Table 2—NAT: Graduate Data—Rural, Underserved, or
Public Health ....................................................................
100
1
100
3.5
350
100
1
100
2.8
280
Total ..............................................................................
* 100
........................
100
........................
630
* The same respondents are completing Tables 1 and Table 2.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2019–23564 Filed 10–28–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Special Emphasis Panel; Conference Support
(R13) Review.
Date: November 19, 2019.
Time: 12:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Telephone Conference Call).
Contact Person: John P. Holden, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 920, Bethesda,
MD 20892, (301) 496–8775, john.holden@
nih.gov.
Dated: October 23, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–23553 Filed 10–28–19; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
VerDate Sep<11>2014
17:05 Oct 28, 2019
Jkt 250001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
U.S. Immigration and Customs
Enforcement
[OMB Control Number 1653–0042]
Agency Information Collection
Activities: Extension of a Currently
Approved Collection: Obligor Change
of Address
U.S. Immigration and Customs
Enforcement, Department of Homeland
Security.
ACTION: 30-Day notice.
AGENCY:
In accordance with the
Paperwork Reductions Act (PRA) of
1995 the Department of Homeland
Security (DHS), U.S. Immigration and
Customs Enforcement (ICE) will submit
the following Information Collection
Request (ICR) to the Office of
Management and Budget (OMB) for
review and clearance. This information
collection was previously published in
the Federal Register on July 24, 2019,
allowing for a 60-day comment period.
ICE received no comments in
connection with the 60-day notice.
Based on better estimates, ICE is making
an adjustment from the 60-day notice to
reflect a decrease in the number of
respondents. The purpose of this notice
SUMMARY:
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 84, Number 209 (Tuesday, October 29, 2019)]
[Notices]
[Page 57879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23553]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Institute
of Biomedical Imaging and Bioengineering Special Emphasis Panel.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; Conference Support (R13)
Review.
Date: November 19, 2019.
Time: 12:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: John P. Holden, Ph.D., Scientific Review
Officer, National Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health, 6707 Democracy
Boulevard, Suite 920, Bethesda, MD 20892, (301) 496-8775,
[email protected].
Dated: October 23, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-23553 Filed 10-28-19; 8:45 am]
BILLING CODE 4140-01-P
